First CoreValve patient, Agnes Pike, receives innovative treatment for aortic stenosis at The University of Kansas Health System in Kansas City, adding years to her life.
A minimally invasive treatment called CoreValve® has revolutionized care for patients with failing aortic valves in Kansas City.
Agnes pike suffered from severe aortic stenosis – a condition in which the heart valve narrows and stiffens. She couldn't get out of bed without assistance. Her life expectancy was 6 months.
Because of her age and other complications, Pike wasn't a candidate for open heart surgery. Her cardiologist at the time, Ashwani Mehta, MD, recommended she participate in a clinical trial for an innovative, minimally invasive treatment called CoreValve. He told her they could talk about the novel procedure, or they could talk about hospice care.
How could I refuse? I couldn't have survived open heart surgery. – Agnes Pike